A study led by researchers at Boston University School of Medicine (BUSM) demonstrates a new mechanism involving a signaling protein and its receptor that may block the formation of new blood vessels and cancer growth. The ...
Nov 28, 2013
5 / 5 (4) | 0 |
An international team of researchers led by the University of Leicester has "harnessed the power of evolution" to create a new drug for possible use against heart disease, inflammation and other illnesses.
Nov 15, 2013
4.2 / 5 (5) | 0 |